Blincyto is a prescription medicine with the active ingredient blinatumomab (API). It belongs to the class of monoclonal antibodies and is categorized under bispecific T-cell engagers (BiTEs). This advanced immunotherapy drug is approved by the US FDA for the treatment of patients with B-cell precursor acute lymphoblastic leukemia (ALL). Blincyto is available in vials containing 38.5 mcg and 35 mcg of lyophilized powder.
The drug works by engaging and activating T-cells, enabling them to target and destroy CD19-positive B-cells, including malignant leukemia cells. By forming a synapse between T-cells and tumor cells, it triggers the release of cytolytic proteins, cytokines, and promotes T-cell proliferation, ultimately leading to the destruction of leukemia cells.
Blincyto (Blinatumomab) is manufactured using CHO (Chinese hamster ovary) cell lines and represents one of the most innovative approaches in modern hematology.
Blincyto (blinatumomab) is a breakthrough immunotherapy option for patients suffering from acute lymphoblastic leukemia (ALL). While the drug is not yet registered in India, it is legally accessible via import blinatumomab India programs. Patients can safely buy blinatumomab in India through authorized suppliers with proper medical prescription and regulatory support.
For updated details on blinatumomab availability India and assistance in securing the best Blincyto price in India, patients and caregivers are encouraged to connect with licensed sourcing experts.
Medical Uses of Blinatumomab
Blincyto (blinatumomab) is indicated for the treatment of:
- CD19-positive B-cell precursor ALL in adult and pediatric patients (≥1 month old) in first or second complete remission with minimal residual disease (MRD ≥0.1%).
- Relapsed or refractory CD19-positive B-cell precursor ALL in both adults and children.
- Philadelphia chromosome-negative CD19-positive B-cell precursor ALL in the consolidation phase of multiphase chemotherapy.
Blincyto infusion is prepared by mixing the powder with a sterile liquid. It is administered as an intravenous (IV) infusion by a trained healthcare provider in a hospital, clinic, or at home under supervision.
Pricing:
Blincyto 38.5 mcg Injection in India is usually prescribed by hematologists and oncologists, especially for patients who are candidates for bone marrow transplant (BMT). However, Blincyto is not registered in India and is not readily available through local pharmacies or standard distribution networks.
Indian patients can buy Blincyto in India through the Named Patient Import License route, which allows access to unregistered drugs for personal medical use. The cost of Blincyto in India may vary, and patients are advised to seek expert guidance for reliable sourcing.
Blincyto is manufactured and promoted by Amgen and may also be referred to by its generic name, blinatumomab. Since it is an imported drug, the Blincyto price in India depends on international supplier costs, shipping, and authorization processes.
Patients, physicians, and hospitals may consult licensed importers to buy blinatumomab in India at the best available price. For updated pricing information and purchase support, contact:
Import Steps:
Since Blincyto is not commercially registered in India, patients must use the legal Named Patient Import Program to obtain it. The process involves:
- Doctor’s Prescription – A treating hematologist/oncologist must prescribe Blincyto for the patient.
- Application for Import – Patients or caregivers apply for a Named Patient Import License through India’s regulatory authority.
- Authorization and Procurement – A licensed supplier arranges for the legal import of Blincyto from authorized international sources.
- Delivery – The medicine is shipped securely to major Indian cities such as Delhi, Mumbai, Bangalore, Kolkata, Hyderabad, Chennai, Pune, Ahmedabad, and others.
This ensures that import of blinatumomab India is safe, legal, and compliant with health regulations.
Access Information:
As Blincyto is not marketed in India through regular distribution, patients can access it only via special import channels. Licensed providers and import facilitators ensure that blinatumomab availability in India is maintained for patients in need.
Blincyto (blinatumomab) can be made available not only across major Indian cities but also in overseas regions like the UK, UAE, Turkey, and Egypt. Patients who require urgent access can benefit from expert assistance in handling documentation, sourcing, and customs clearance.
With proper medical prescription and regulatory approvals, patients can buy Blincyto injection in India legally and access the therapy without unnecessary delays.
To buy Blincyto in India or know the latest Blincyto price, visit 247qualitymeds.com for trusted guidance and secure ordering.